AnalysisNews

MED today

$12.97+$0.11 (+0.86%)close Nov 13, 2026

Trend

DailyUptrend (confirmed)

4 hourBearish

1 hourSymmetric Triangle

15 minBullish

5 minStrong Bearish

Daily trend turns down below $11.26

Key levels

Resistance$13.63

Resistance$13.08

Support$12.37

Support$11.71

Latest news & SEC filings

SEC FilingMedifast Inc filed an insider trading report (Form 4)

GuidanceMedartis lifts full-year 2026 growth forecast on US performance

All MED news →

About Medifast

Medifast is a health and wellness company that sells weight-loss and metabolic health products through independent coaches. Its product lines include OPTA VIA meal replacements, ACTIVE sports nutrition items, and ASCEND mini meals. Coaches, who are independent contractors rather than employees, promote the brand through personal networks and online channels, and products ship directly to customers. The company operates primarily in the United States.

Based on the company's 10-K filed Feb 17, 2026.

NYSE · Consumer Defensive

MEDIFAST INC (MED)

$12.97+0.11 (+0.86%)
WATCHLISTGrade: BRisk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
11.8212.2112.5912.9812.97Oct 13Oct 21Oct 29Nov 6
High13.02
Low12.77
Open12.95
Volume58K
Avg Vol114K
VWAP12.93
30d High13.37
30d Low11.43
30d Chg+11.14%

What Is the Price Target for MED?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $12.97Upside: +0.0%Confidence: 20%Method: No Coverage

Is MED a Buy or Sell Right Now?

57
Investability Score
WATCHLIST12-18 months

Thesis

  • •Revenue growing -36.0% YoY with ACCELERATING trend — accelerating momentum.
  • •Smart money flows are positive — institutional and insider activity shows net buying.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MED.

Start Free Trial →

Is MED Overvalued or Undervalued?

Valuation Verdict

FAIR

Methods Used

P/B, PEG

Fair Value

$14.05

45

Moat Score

NARROW

4/9

Piotroski Score

4.6

Altman Z-Score

What Is Smart Money Doing with MED?

Insider Signal

BUYING

5 buys / 2 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

DISTRIBUTING

Short Squeeze Risk

LOW

Signal: NEUTRAL

Recent Insider Activity

NameTitleTypeSharesValueDate
Kiai ParsadirectorBuy661$9KNov 4, 2026
Kiai ParsadirectorBuy5,399$66KOct 28, 2026
Kiai ParsadirectorBuy158$2KOct 28, 2026
Chard Daniel RdirectorSale9,544$112KSep 29, 2026
Chard Daniel RdirectorSale9,545$114KSep 28, 2026
Kiai ParsadirectorBuy41,975$515KAug 26, 2026
Kiai ParsadirectorBuy1,175$14KAug 26, 2026
Rose Jeffrey MatthewdirectorBuy11,680-May 26, 2026
Rose Jeffrey MatthewdirectorBuy6,739-May 26, 2026
Kiai ParsadirectorBuy11,680-May 26, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

MED Growth Story

Revenue YoY

-36.0%

3yr Revenue CAGR

N/A%

EPS Growth YoY

-994.74%

FCF Growth YoY

-92.7%

Revenue Trend

ACCELERATING

Dark Pool Trades for MED

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for MED, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
18:40:55$12.861,000$$13KSELL
18:40:53$12.881,555$$20KBUY
18:45:45$13.231,706$$23KSELL
18:45:44$13.261,000$$13KMIDPOINT
20:28:16$13.102,200$$29KSELL

5 dark pool trades shown · $$98K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for MEDIFAST INC (MED) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

MED — frequently asked questions

What is MED stock price today?

MEDIFAST INC (MED) is at $12.97, up 0.86% (+$0.11) at the Nov 13, 2026 close.

Why is MED stock moving today?

Latest MED news — Nov 6, 2026: Medifast Inc filed an insider trading report (Form 4) · Nov 2, 2026: Medartis lifts full-year 2026 growth forecast on US performance

Did MED beat earnings?

MED last reported on Aug 3, 2026: EPS -$0.28 vs -$0.65 expected — a beat of 56.9%.

Does MED pay a dividend?

Yes. MED's dividend yield is 0.17%.

What are MED support and resistance levels?

Support: $12.37, $11.71, $11.26. Resistance: $13.08, $13.63, $14.15.

What are insiders doing with MED?

Insider activity: BUYING, 5 buys and 2 sells in the last 90 days.

What is the latest news on MED?

Nov 6, 2026: Medifast Inc filed an insider trading report (Form 4) · Nov 2, 2026: Medartis lifts full-year 2026 growth forecast on US performance